DelMar Pharmaceuticals CEO Saiid Zarrabian receives $939.0K in 2018
DelMar Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: May 14, 2019
DelMar Pharmaceuticals reported fiscal year 2018 executive compensation information on May 14, 2019.
In 2018, four executives at DelMar Pharmaceuticals received on average a compensation package of $502.2K, a 4% increase compared to previous year.
Saiid Zarrabian, Chief Executive Officer, received $939K in total. 65.60% of Zarrabian's compensation, or $616K, was in option awards. Zarrabian also received $85.6K in bonus and $237.4K in salary.
Jeffrey Bacha, Chief Executive Officer, received a compensation package of $659.9K, which increased by 8% compared to previous year. 81.46% of the compensation package, or $537.6K, was in salary.
Scott Praill, Chief Financial Officer, earned $210K in 2018, a 45% decrease compared to previous year.
Dennis Brown, Chief Scientific Officer, received $200K in 2018, which decreases by 57% compared to 2017.
DelMar Pharmaceuticals' fiscal year ends on June 30.